MK-9470
MK-9470 is a radioligand used in positron emission tomography (PET) imaging to study the cannabinoid receptor type 1 (CB1R) in the human brain. It is a synthetic compound developed by Merck & Co. for research purposes.
Chemical Properties
MK-9470 is a selective CB1R antagonist, which means it binds specifically to the CB1 receptors in the brain, blocking the action of endogenous cannabinoids. This property makes it useful for mapping the distribution and density of CB1 receptors in various regions of the brain.
Mechanism of Action
As a CB1R antagonist, MK-9470 competes with endogenous cannabinoids like anandamide and 2-arachidonoylglycerol (2-AG) for binding to the CB1 receptors. By doing so, it inhibits the normal action of these endogenous ligands, allowing researchers to study the role of CB1 receptors in various physiological and pathological processes.
Applications in Research
MK-9470 has been used extensively in neuroscience research to investigate the role of the endocannabinoid system in various conditions, including neurodegenerative diseases, psychiatric disorders, and substance abuse. PET imaging with MK-9470 allows for the visualization and quantification of CB1 receptor distribution in the living brain, providing valuable insights into the functioning of the endocannabinoid system.
Safety and Efficacy
As a research compound, MK-9470 is not intended for therapeutic use in humans. Its safety and efficacy have been evaluated in preclinical studies and clinical trials primarily to understand its binding characteristics and potential as a diagnostic tool.
Related Compounds
Other radioligands used for imaging CB1 receptors include AM251, SR141716A (Rimonabant), and CP-55940. These compounds vary in their selectivity and affinity for CB1 receptors, offering different advantages and limitations for research purposes.
See Also
References
External Links
receptor antagonists| |_}} {{#replace:Cannabinoid receptor antagonists| |_}}
.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD